Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
European Journal of Immunology
|
September 5, 2002
MHC class II isotype-specific signaling complex on human B cells
Claire Lévéille, Jean-Gabriel Castaigne, Dominique Charron, et al.
Journal of Medical Economics
|
December 7, 2013
Bendamustine-rituximab: a cost-utility analysis in first-line treatment of indolent non-Hodgkin's lymphoma in England and Wales
Sarah Dewilde, Beth Woods, Jean-Gabriel Castaigne, et al.
Pharmacoeconomics
|
January 6, 2019
Modeling Covariate-Adjusted Survival for Economic Evaluations in Oncology
Istvan M Majer, Jean-Gabriel Castaigne, Stephen Palmer, et al.
European Journal of Immunology
|
April 3, 2003
Signaling through HLA-DR induces PKC beta-dependent B cell death outside rafts
Wenyan Guo, Jean-Gabriel Castaigne, Nuala Mooney, et al.
International Immunology
|
August 31, 2002
A CD18-dependent protein kinase C beta-mediated alternative cell death pathway of activated monocytes
Jean-Gabriel Castaigne, Wenyan Guo, Claire Lévéille, et al.
Biochemical Society Transactions
|
September 23, 2011
Combining modelling and mutagenesis studies of synaptic vesicle protein 2A to identify a series of residues involved in racetam binding
Jiye Shi, Dina Anderson, Berkley A Lynch, et al.
Advances in Therapy
|
September 24, 2024
A Cost-Effectiveness Analysis of Axicabtagene Ciloleucel versus Tisagenlecleucel in the Treatment of Diffuse Large B-cell Lymphoma Based on a Real-World French Registry
Markqayne Ray, Jean-Gabriel Castaigne, Alexandra Zang, et al.
Experimental Cell Research
|
August 11, 2004
HLA-DR signaling inhibits Fas-mediated apoptosis in A375 melanoma cells
Fawzi Aoudjit, Wenyan Guo, Jean-Vincent Gagnon-Houde, et al.
Molecular Immunology
|
August 28, 2007
The context of HLA-DR/CD18 complex in the plasma membrane governs HLA-DR-derived signals in activated monocytes
Jean-Marc Doisne, Jean-Gabriel Castaigne, Carine Deruyffelaere, et al.
Advances in Therapy
|
June 21, 2022
Cost-Effectiveness of KTE-X19 for Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia in the United States
Bijal D Shah, Nathaniel J Smith, Chaoling Feng, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
European Journal of Immunology
|
September 5, 2002
MHC class II isotype-specific signaling complex on human B cells
Claire Lévéille, Jean-Gabriel Castaigne, Dominique Charron, et al.
Journal of Medical Economics
|
December 7, 2013
Bendamustine-rituximab: a cost-utility analysis in first-line treatment of indolent non-Hodgkin's lymphoma in England and Wales
Sarah Dewilde, Beth Woods, Jean-Gabriel Castaigne, et al.
Pharmacoeconomics
|
January 6, 2019
Modeling Covariate-Adjusted Survival for Economic Evaluations in Oncology
Istvan M Majer, Jean-Gabriel Castaigne, Stephen Palmer, et al.
European Journal of Immunology
|
April 3, 2003
Signaling through HLA-DR induces PKC beta-dependent B cell death outside rafts
Wenyan Guo, Jean-Gabriel Castaigne, Nuala Mooney, et al.
International Immunology
|
August 31, 2002
A CD18-dependent protein kinase C beta-mediated alternative cell death pathway of activated monocytes
Jean-Gabriel Castaigne, Wenyan Guo, Claire Lévéille, et al.
Biochemical Society Transactions
|
September 23, 2011
Combining modelling and mutagenesis studies of synaptic vesicle protein 2A to identify a series of residues involved in racetam binding
Jiye Shi, Dina Anderson, Berkley A Lynch, et al.
Advances in Therapy
|
September 24, 2024
A Cost-Effectiveness Analysis of Axicabtagene Ciloleucel versus Tisagenlecleucel in the Treatment of Diffuse Large B-cell Lymphoma Based on a Real-World French Registry
Markqayne Ray, Jean-Gabriel Castaigne, Alexandra Zang, et al.
Experimental Cell Research
|
August 11, 2004
HLA-DR signaling inhibits Fas-mediated apoptosis in A375 melanoma cells
Fawzi Aoudjit, Wenyan Guo, Jean-Vincent Gagnon-Houde, et al.
Molecular Immunology
|
August 28, 2007
The context of HLA-DR/CD18 complex in the plasma membrane governs HLA-DR-derived signals in activated monocytes
Jean-Marc Doisne, Jean-Gabriel Castaigne, Carine Deruyffelaere, et al.
Advances in Therapy
|
June 21, 2022
Cost-Effectiveness of KTE-X19 for Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia in the United States
Bijal D Shah, Nathaniel J Smith, Chaoling Feng, et al.
Page
of 2